TY  - JOUR
AU  - Aparicio Blanco, Juan
AU  - Sanz-Arriazu, Lorena 
AU  - Lorenzoni, Ricardo 
AU  - Blanco-Prieto, María J. 
PY  - 2020
DO  - 10.1016/j.ijpharm.2020.119283
SN  - 0378-5173
UR  - https://hdl.handle.net/20.500.14352/97399
T2  - International Journal of Pharmaceutics
AB  - Even though substantial advances in understanding glioma pathogenesis have prompted a more rational design of potential therapeutic strategies, glioblastoma multiforme remains an incurable disease with the lowest median overall survival among all...
LA  - eng
PB  - Elsevier
KW  - Nanoparticles
KW  - Nanomedicine
KW  - Glioblastoma
KW  - Brain drug delivery
KW  - Blood-brain barrier
KW  - Drug targeting
KW  - Clinical trials
TI  - Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy
TY  - journal article
VL  - 581
ER  -